Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
The New York Proton Center
Beijing Biotech
Parabilis Medicines, Inc.
Orano Med LLC
Filamon LTD
AstraZeneca
Essen Biotech
Essen Biotech
Sapience Therapeutics
Mayo Clinic
Mayo Clinic
Dana-Farber Cancer Institute
Incyte Corporation
Maastricht Radiation Oncology
Dana-Farber Cancer Institute
Washington University School of Medicine
Fudan University
Jonsson Comprehensive Cancer Center
University of California, San Francisco
Eli Lilly and Company
Columbia University
Xijing Hospital
Cedars-Sinai Medical Center
Algemeen Ziekenhuis Maria Middelares
National Cancer Institute (NCI)
Universidade Federal de Pernambuco
Mayo Clinic
Peking Union Medical College Hospital
Cedars-Sinai Medical Center
M.D. Anderson Cancer Center
Nuvation Bio Inc.
Eastern Cooperative Oncology Group
Quadriga Biosciences, Inc.
Alliance for Clinical Trials in Oncology
Celgene
Hospices Civils de Lyon
Celgene
Maastricht Radiation Oncology
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Stanford University
SWOG Cancer Research Network
Chang Gung Memorial Hospital
Roswell Park Cancer Institute
Memorial Sloan Kettering Cancer Center
Alliance for Clinical Trials in Oncology
University of Southern California
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Chinese PLA General Hospital